Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3297714rdf:typepubmed:Citationlld:pubmed
pubmed-article:3297714lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:3297714lifeskim:mentionsumls-concept:C0079083lld:lifeskim
pubmed-article:3297714lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:3297714lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:3297714pubmed:issue1lld:pubmed
pubmed-article:3297714pubmed:dateCreated1987-8-17lld:pubmed
pubmed-article:3297714pubmed:abstractTextA dose of 170 mg/kg of carboplatin is lethal in mice, death occurring through bone marrow failure. This lethality can be avoided by giving the animals 200 mg/kg cyclophosphamide 1 or 2 days before this dose of carboplatin. The improved normal tissue tolerance cannot be explained by altered pharmacokinetics of carboplatin. Increased survival appears to be associated with a more rapid regeneration of the haemopoietic stem cells. Tumour tissue is not protected in the same way and thus a therapeutic gain can be achieved using this protocol.lld:pubmed
pubmed-article:3297714pubmed:languageenglld:pubmed
pubmed-article:3297714pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3297714pubmed:citationSubsetIMlld:pubmed
pubmed-article:3297714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3297714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3297714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3297714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3297714pubmed:statusMEDLINElld:pubmed
pubmed-article:3297714pubmed:monthJanlld:pubmed
pubmed-article:3297714pubmed:issn0277-5379lld:pubmed
pubmed-article:3297714pubmed:authorpubmed-author:SiddikZ HZHlld:pubmed
pubmed-article:3297714pubmed:authorpubmed-author:SmithI EIElld:pubmed
pubmed-article:3297714pubmed:authorpubmed-author:SloaneJ PJPlld:pubmed
pubmed-article:3297714pubmed:authorpubmed-author:MillarJ LJLlld:pubmed
pubmed-article:3297714pubmed:authorpubmed-author:GoreM EMElld:pubmed
pubmed-article:3297714pubmed:authorpubmed-author:HillsC ACAlld:pubmed
pubmed-article:3297714pubmed:authorpubmed-author:WinkleyA RARlld:pubmed
pubmed-article:3297714pubmed:issnTypePrintlld:pubmed
pubmed-article:3297714pubmed:volume23lld:pubmed
pubmed-article:3297714pubmed:ownerNLMlld:pubmed
pubmed-article:3297714pubmed:authorsCompleteYlld:pubmed
pubmed-article:3297714pubmed:pagination75-80lld:pubmed
pubmed-article:3297714pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:meshHeadingpubmed-meshheading:3297714-...lld:pubmed
pubmed-article:3297714pubmed:year1987lld:pubmed
pubmed-article:3297714pubmed:articleTitlePriming reduces the bone marrow toxicity of carboplatin.lld:pubmed
pubmed-article:3297714pubmed:publicationTypeJournal Articlelld:pubmed